Iron metabolism in end-stage renal disease

被引：4

作者：

Barth, RH ^{[1
]}

机构：

[1] Vet Adm Med Ctr, Nephrol Sect, Dept Med, Brooklyn, NY 11209 USA

来源：

关键词：

D O I：

10.1046/j.1525-139X.1999.99025.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：224 / 230

页数：7

共 50 条

[21] Thrombosis in end-stage renal disease
Casserly, LF
Dember, LM
SEMINARS IN DIALYSIS, 2003, 16 (03) : 245 - 256
[22] Lipids in end-stage renal disease
Wanner, C
JOURNAL OF NEPHROLOGY, 2002, 15 (02) : 202 - 204
[23] Osteoporosis in end-stage renal disease
Lindberg, JS
Moe, SM
SEMINARS IN NEPHROLOGY, 1999, 19 (02) : 115 - 122
[24] Keloids and end-stage renal disease
Freedman, BI
Morrow, MA
Tuttle, AB
Igwemezie, BM
Rich, SS
Sherertz, EF
Tuttlea, FNAJANAEB
NEPHRON, 1998, 80 (02): : 244 - 246
[25] Adiponectin and end-stage renal disease
Markaki, Anastasia
Psylinakis, Emmanuel
Spyridaki, Aspasia
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2016, 15 (03): : 345 - 354
[26] Hypertension in end-stage renal disease
Martínez-Maldonado, M
KIDNEY INTERNATIONAL, 1998, 54 : S67 - S72
[27] End-Stage Renal Disease and Pregnancy
Nadeau-Fredette, Annie-Claire
Hladunewich, Michelle
Hui, Dini
Keunen, Johannes
Chan, Christopher T.
ADVANCES IN CHRONIC KIDNEY DISEASE, 2013, 20 (03) : 246 - 252
[28] Pregnancy and End-Stage Renal Disease
Tangren, Jessica
Nadel, Molly
Hladunewich, Michelle A.
BLOOD PURIFICATION, 2018, 45 (1-3) : 194 - 200
[29] Adiponectin and end-stage renal disease
Markaki A.
Psylinakis E.
Spyridaki A.
Hormones, 2016, 15 (3) : 345 - 354
[30] Pharmacotherapy of end-stage renal disease
Schmid, Holger
Schiffl, Helmut
Lederer, Stephan R.
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (04) : 597 - 613